United States · FDA National Drug Code directory
Lopinavir and ritonavir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-556_c3de2763-2221-d566-e053-2995a90ab15f
- Product NDC
- 31722-556
- Form
- TABLET, FILM COATED
- Composition / generic term
- Lopinavir and ritonavir
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210607
- Source listing expiry
- 20261231
Source-listed ingredients
- LOPINAVIR — 200 mg/1
- RITONAVIR — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET, FILM COATED in 1 BOTTLE (31722-556-12) · 31722-556-12
- 8 BLISTER PACK in 1 CARTON (31722-556-31) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 31722-556-31
- 8 BLISTER PACK in 1 CARTON (31722-556-32) / 10 TABLET, FILM COATED in 1 BLISTER PACK · 31722-556-32
- 60 TABLET, FILM COATED in 1 BOTTLE (31722-556-60) · 31722-556-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →